Cancer of esophagus and GE junction– a long-term follow-up results

Background:  Esophageal and GE Junction malignancies are diagnosed late and the long-term outcome is still suboptimal. We present our experience. Methods: 421 patients with mean age of 57.6 years with cancer of esophagus and GE Junction were evaluated with physical examination, CT chest and abdome...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Binay Thakur, Di Yonghui, Mukti Devkota, Paribartan Baral, Sudhir Shrestha, Janaki Upreti, Nirmala Kandel
Formato: article
Lenguaje:EN
Publicado: Society of Surgeons of Nepal 2016
Materias:
Acceso en línea:https://doaj.org/article/ba383eac5eaa469989be0fd7c96960b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ba383eac5eaa469989be0fd7c96960b2
record_format dspace
spelling oai:doaj.org-article:ba383eac5eaa469989be0fd7c96960b22021-12-05T19:16:42ZCancer of esophagus and GE junction– a long-term follow-up results10.3126/jssn.v18i3.152841815-39842392-4772https://doaj.org/article/ba383eac5eaa469989be0fd7c96960b22016-07-01T00:00:00Zhttps://www.nepjol.info/index.php/JSSN/article/view/15284https://doaj.org/toc/1815-3984https://doaj.org/toc/2392-4772 Background:  Esophageal and GE Junction malignancies are diagnosed late and the long-term outcome is still suboptimal. We present our experience. Methods: 421 patients with mean age of 57.6 years with cancer of esophagus and GE Junction were evaluated with physical examination, CT chest and abdomen, gastroduodenoscopy and bronchoscopy. 254 (60.4%) patients underwent surgical treatment only and 167 (39.6%) underwent multimodality treatment. 295 patients underwent transthoracic approach, 88 – transhiatal approach and 58 patients underwent – abdominal approach only. Results: Upper, middle, GEJ type – I, GEJ type – II, GEJ type – III tumors were present in 5.7, 28.5, 36.8 and 1.9% cases, respectively. Anastomosis was placed at neck in 73.2% and in chest in 26.8% cases. Final stages were 0 (0.2%), Ia (0.5%), Ib (1.9%), IIa (10%), IIb (8.8%), IIIa (15.7%), IIIb (14.3%), IIIc (41.6%) and IV (7.1%). R0 resection was achieved in 91.5% cases. Postoperative mortality, recurrent laryngeal nerve injury, anastomotic leak and pneumonia were observed in 4.8%, 5.7%, 11.6% and 22.1%, respectively. Median overall survival was 28 months with 5-year overall survival of 21%. A subgroup of 70 patients (16.6%) who were subjected to preoperative chemoradiation followed by surgery showed response in 64.3% cases with a median and 5-year survival of 49 months and 30% in responders, and 15 months and 15% in non-responders. Conclusion: Patients presented mostly in stage III (78.7%), therefore a multimodality approach should be considered as a standard practice in Nepalese context in order to achieve better survival results. Binay ThakurDi YonghuiMukti DevkotaParibartan BaralSudhir ShresthaJanaki UpretiNirmala KandelSociety of Surgeons of NepalarticleSurgeryRD1-811ENJournal of Society of Surgeons of Nepal, Vol 18, Iss 3 (2016)
institution DOAJ
collection DOAJ
language EN
topic Surgery
RD1-811
spellingShingle Surgery
RD1-811
Binay Thakur
Di Yonghui
Mukti Devkota
Paribartan Baral
Sudhir Shrestha
Janaki Upreti
Nirmala Kandel
Cancer of esophagus and GE junction– a long-term follow-up results
description Background:  Esophageal and GE Junction malignancies are diagnosed late and the long-term outcome is still suboptimal. We present our experience. Methods: 421 patients with mean age of 57.6 years with cancer of esophagus and GE Junction were evaluated with physical examination, CT chest and abdomen, gastroduodenoscopy and bronchoscopy. 254 (60.4%) patients underwent surgical treatment only and 167 (39.6%) underwent multimodality treatment. 295 patients underwent transthoracic approach, 88 – transhiatal approach and 58 patients underwent – abdominal approach only. Results: Upper, middle, GEJ type – I, GEJ type – II, GEJ type – III tumors were present in 5.7, 28.5, 36.8 and 1.9% cases, respectively. Anastomosis was placed at neck in 73.2% and in chest in 26.8% cases. Final stages were 0 (0.2%), Ia (0.5%), Ib (1.9%), IIa (10%), IIb (8.8%), IIIa (15.7%), IIIb (14.3%), IIIc (41.6%) and IV (7.1%). R0 resection was achieved in 91.5% cases. Postoperative mortality, recurrent laryngeal nerve injury, anastomotic leak and pneumonia were observed in 4.8%, 5.7%, 11.6% and 22.1%, respectively. Median overall survival was 28 months with 5-year overall survival of 21%. A subgroup of 70 patients (16.6%) who were subjected to preoperative chemoradiation followed by surgery showed response in 64.3% cases with a median and 5-year survival of 49 months and 30% in responders, and 15 months and 15% in non-responders. Conclusion: Patients presented mostly in stage III (78.7%), therefore a multimodality approach should be considered as a standard practice in Nepalese context in order to achieve better survival results.
format article
author Binay Thakur
Di Yonghui
Mukti Devkota
Paribartan Baral
Sudhir Shrestha
Janaki Upreti
Nirmala Kandel
author_facet Binay Thakur
Di Yonghui
Mukti Devkota
Paribartan Baral
Sudhir Shrestha
Janaki Upreti
Nirmala Kandel
author_sort Binay Thakur
title Cancer of esophagus and GE junction– a long-term follow-up results
title_short Cancer of esophagus and GE junction– a long-term follow-up results
title_full Cancer of esophagus and GE junction– a long-term follow-up results
title_fullStr Cancer of esophagus and GE junction– a long-term follow-up results
title_full_unstemmed Cancer of esophagus and GE junction– a long-term follow-up results
title_sort cancer of esophagus and ge junction– a long-term follow-up results
publisher Society of Surgeons of Nepal
publishDate 2016
url https://doaj.org/article/ba383eac5eaa469989be0fd7c96960b2
work_keys_str_mv AT binaythakur cancerofesophagusandgejunctionalongtermfollowupresults
AT diyonghui cancerofesophagusandgejunctionalongtermfollowupresults
AT muktidevkota cancerofesophagusandgejunctionalongtermfollowupresults
AT paribartanbaral cancerofesophagusandgejunctionalongtermfollowupresults
AT sudhirshrestha cancerofesophagusandgejunctionalongtermfollowupresults
AT janakiupreti cancerofesophagusandgejunctionalongtermfollowupresults
AT nirmalakandel cancerofesophagusandgejunctionalongtermfollowupresults
_version_ 1718371087986720768